Sign In

Emily R. Lowry, Ph.D.

Co-Scientific Director, Project ALS Therapeutics Core at Columbia University

Dr. Emily R. Lowry is a distinguished professional with a strong background in Neurobiology and Genetics. She holds a Doctor of Philosophy (Ph.D.) from The Rockefeller University, where she specialized in Neurobiology and Genetics. Prior to her Ph.D., she completed a Bachelor of Arts (B.A.) in Neuroscience and Behavior, with a Cellular Concentration at Barnard College, and another B.A. in Neuroscience, also with a Cellular Concentration, at Columbia University.

Throughout her career, Dr. Lowry has held key positions in various prestigious organizations. She served as the Co-Scientific Director at the Project ALS Therapeutics Core at Columbia University Irving Medical Center. Additionally, she took on the role of Scientific Co-Founder and Senior Scientific Advisor at ProJenX, Inc. Dr. Lowry also worked as the Director of Operations at the Project ALS Therapeutics Core, further showcasing her organizational and leadership skills.

Dr. Lowry's early career includes roles such as Associate Research Scientist, Postdoctoral Research Scientist, and Graduate Fellow at Columbia University Irving Medical Center and The Rockefeller University. She also gained valuable experience as a Research Assistant at Columbia University Medical Center and Barnard College, and as an Intern at Mahidol University and UCSF.

Dr. Lowry's extensive professional background demonstrates her expertise in neurobiology, genetics, and research management. She has contributed significantly to the field through her research and leadership roles in academia and industry.

Highlights

Apr 5 · linkedin

A collaboration with Tulsi Patel and Hynek Wichterle that started out as a wild idea is now out in the world as a preprint!

Since aging plays a key role in ALS and other late-onset neurodegenerative disorders, we were wondering whether returning aged neurons to a more youthful state might restore their native resilience to disease. To get at this question we used AAVs to deliver embryonic motor neuron genes back to postnatal motor neurons in live mice. We found that the AAVs could shift gene expression in mature motor neurons back to a younger state. In a mouse model of ALS, the AAVs suppressed markers of motor neuron stress and kept the animals healthier for longer.

Lots to follow up on and very excited to keep moving forward. A big thanks to Project ALS for their support throughout this project (even when it seemed like it might never work!)

E
Add to my network

Location

New York, New York, United States